10-Q: Aeluma Reports Q3 2026 Results: Revenue Down, Expenses Up

Aeluma, Inc. reported a substantial decrease in revenue and a significant increase in operating expenses for the third quarter of 2026, resulting in a widened net loss.

Summary

• Aeluma, Inc. reported a net loss of $3.76 million for the three months ended September 30, 2026, a significant increase from the $1.49 million loss in the same period of 2025.
• Revenue for the quarter decreased by 59% to $0.57 million, down from $1.39 million in the prior year's quarter.
• Operating expenses rose by 61% to $4.82 million, driven by increased compensation, R&D, and general administrative costs.
• The company ended the quarter with $53.88 million in cash and cash equivalents.
• Aeluma is transitioning from an R&D stage to commercialization, with revenue from government contracts and emerging commercial sales.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as negative due to a significant revenue decline and increased operating expenses, leading to a wider net loss, despite a strong cash position and potential future funding.

Positives

• Maintains a strong cash position with $53.88 million in cash and cash equivalents as of September 30, 2026.
• Potential for up to $30 million in funding from the U.S. Department of Commerce under the CHIPS and Science Act, subject to due diligence and approvals.
• Has $29.3 million remaining available under its at-the-market (ATM) offering program.
• The company is actively working on advancing product development and customer qualifications for commercialization.

Negatives

• Revenue for the three months ended September 30, 2026, decreased by 59% to $0.57 million, compared to $1.39 million in the same period of 2025.
• Operating expenses increased by 61% to $4.82 million for the three months ended September 30, 2026, compared to $3.00 million in the same period of 2025.
• Net loss widened significantly to $3.76 million for the three months ended September 30, 2026, from $1.49 million in the prior year period.
• Net loss per share increased to $(0.19) from $(0.09) year-over-year.

Risks

• The company's revenue is heavily concentrated among a few customers, with 67% of revenue derived from three customers in the three months ended September 30, 2026.
• A material weakness in internal control over financial reporting was identified due to an insufficient number of personnel with appropriate technical accounting capabilities.
• The company's transition to commercialization is dependent on several factors including technical performance, customer qualification, and market demand.
• The proposed funding from the CHIPS and Science Act is not a committed source of liquidity until definitive agreements are executed and conditions are met.

Future Outlook

The company expects to continue investing in engineering, materials growth, wafer fabrication, packaging, testing, quality systems, sales, and business development. They plan to supply engineering samples, prototype wafers and chips, small volume products, and development services while customers evaluate their technology. The timing and scale of commercialization depend on technical performance, reliability, customer qualification, product design, supply chain readiness, and market demand. The company believes its current cash position and ability to raise funds via the ATM program will be sufficient for operations and capital expenditures for the next twelve months and beyond.

Management Comments

• Management believes the consolidated financial statements included in this report fairly present, in all material respects, our financial position, results of operations, and cash flows for the periods presented in conformity with GAAP.
• Management continues to implement corrective actions to remediate the identified material weakness, including increasing accounting resources, enhancing the review and oversight of significant and non-routine transactions, and further developing and formalizing our internal control framework.

Industry Context

StockSavvy.ai notes that Aeluma operates in the highly competitive and rapidly evolving photonic and electronic technologies sector, serving markets like telecom, AI datacom, and AR/VR. The company's capital-efficient manufacturing model, combining internal capabilities with external partners, is a common strategy in this industry to manage costs and scale production. The increasing demand for high-performance components in AI and data centers presents a significant opportunity, but also intensifies competition and the need for continuous innovation and reliable supply chains.

Comparison to Industry Standards

• The revenue decline of 59% is a significant concern, especially when compared to the growth rates often seen in the AI datacom and telecom infrastructure sectors, where companies are typically experiencing strong demand.
• The increase in operating expenses by 61% while revenue declines suggests potential inefficiencies or significant investments in R&D and scaling that have not yet translated into commercial success, a trend that needs careful monitoring against industry benchmarks for R&D spend as a percentage of revenue.
• The company's focus on photodetectors, lasers, and optical amplifiers aligns with key technology trends in high-speed communication and sensing, areas where industry leaders are investing heavily.
• The material weakness in internal controls is a red flag that could be viewed unfavorably compared to more mature companies in the semiconductor and photonics industry that typically have robust control environments.

Corporate Governance

Legal Proceedings

• The company is not currently involved in any material legal proceedings, but may be involved in future proceedings arising in the ordinary course of business.

Stakeholder Impact

• Shareholders: The widening net loss and revenue decline may negatively impact shareholder value in the short term. However, the strong cash position and potential future funding sources offer some stability.
• Employees: Increased operating expenses include higher compensation and related costs, indicating continued investment in personnel, which could be positive for employee morale and growth, but is contingent on future success.
• Customers: The company's reliance on a few key customers for revenue could pose a risk if those relationships are disrupted. The transition to commercialization implies a focus on meeting customer needs for product qualification and delivery.
• Suppliers/Creditors: The company's liquidity position appears adequate for the near term, suggesting continued ability to meet obligations.

Next Steps

• Advance product development.
• Complete customer and manufacturing qualifications.
• Deliver on existing commercial and government contracts.
• Increase manufacturing readiness.
• Convert qualified customer engagements into recurring product revenue.
• Continue investing in engineering, materials growth, wafer fabrication, packaging, testing, quality systems, sales, and business development.
• Continue working with prospective customers, system integrators, and supply chain partners.
• Continue to assess capital requirements and pursue additional financing opportunities if needed.

Key Dates

Recommendation

While the company possesses a strong cash position and potential future funding, the significant decline in revenue and increase in operating expenses leading to a wider net loss are concerning. The identified material weakness in internal controls also warrants caution. The company's transition to commercialization is still in its early stages, and the outcome remains uncertain. A 'hold' recommendation reflects a balanced view of the risks and potential rewards, pending clearer signs of revenue recovery and operational improvements.

Keywords

photonic technologies, electronic technologies, telecom, AI datacom, semiconductor, quantum dot, R&D, commercialization